Vanguard Group Inc Roivant Sciences Ltd. Call Options Transaction History
Vanguard Group Inc
- $5.57 Trillion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ROIV
# of Institutions
332Shares Held
505MCall Options Held
573KPut Options Held
739K-
Qvt Financial LP New York, NY65.8MShares$700 Million76.3% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X062.1MShares$660 Million6.45% of portfolio
-
Viking Global Investors LP47.8MShares$509 Million1.91% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$376 Million0.01% of portfolio
-
Morgan Stanley New York, NY34.6MShares$368 Million0.03% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.49B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...